Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation

Journal of Immunology

Volumn 168, Issue 8, 2002, Pages 3847-3854

  Zhou, Xu Yu ^a   Yashiro Ohtani, Yumi ^a   Nakahira, Masakiyo ^a   Park, Woong Ryeon ^a   Abe, Ryo ^a   Hamaoka, Toshiyuki ^a   Naramura, Mayumi ^a   Gu, Hua ^a   Fujiwara, Hiromi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE INACTIVATION; GENETIC CODE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION; TIME;

EID: 0037090259     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.8.3847     Document Type: Article

References (56)

1. A cell culture model for T lymphocyte clonal anergy
2. Costimulation of T-cell growth
3. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
4. The role of the CD28 receptor during T cell responses to antigen
5. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
6. + T cells
7. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
8. Abs to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells
9. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor
10. CD44 contributes to T cell activation
11. A role for CD9 molecules in T cell activation
12. T cell co-stimulatory molecules other than CD28
13. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other costimulatory molecules
14. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts
15. Signal transmission between the plasma membrane and nucleus of T lymphocytes
16. Transcriptional regulation of the IL-2 gene
17. Identification of a putative regulator of early T cell activation genes
18. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
19. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
20. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway
21. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28
22. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy
23. Mice with a fluorescent marker for interleukin 2 gene activation
24. Identification of a monoclonal Ab specific for a murine T3 polypeptide
25. + splenic T cells after CD28 receptor ligation
26. Xenogeneic monoclonal Abs to mouse lymphoid differentiation antigens
27. Monoclonal Abs to mouse major histocompatibility complex antigens
28. - T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18
29. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor
30. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis
31. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40
32. Regulation of cytokine gene expression in T helper cell subsets
33. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IκBα degradation
34. IκB: A specific inhibitor of the NF-κB transcription factor
35. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
36. IκBβ regulates the persistent response in a biphasic activation of NF-κB
37. CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers
38. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators
39. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors
40. Enhanced stability of interleukin-2 mRNA in MLA 144 cells: Possible role of cytoplasmic AU-rich sequence-binding proteins
41. CD28-Mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA
42. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation
43. The interleukin 2 CD28-responsive complex contains at least three members of the NF κB family: c-Rel, p50, and p65
44. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells
45. 75 B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression
46. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors
47. Function and activation of NF-κB in the immune system
48. The NF-κB and IκB proteins: New discoveries and insights
49. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
50. + T lymphocytes
51. Signal transduction through NF-κB
52. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
53. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL
54. L expression by human T-cell leukemia virus type 1 Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax
55. NF-κB-mediated up-regulation of Bcl-X and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
56. + lymphocytes